1. The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis
- Author
-
Wei BJ, Yao MY, Xing CY, Wang W, Yao J, Hong Y, Liu Y, and Fu PF
- Subjects
neutrophil lymphocyte ratio ,Breast cancer ,prognosis ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,lcsh:RC254-282 ,meta analysis - Abstract
Bajin Wei,1,2 Minya Yao,1 Chunyang Xing,2 Wei Wang,2 Jia Yao,1 Yun Hong,1 Yu Liu,1 Peifen Fu1,2 1Diagnosis and Treatment of Breast Diseases Center, 2Key Laboratory of Organ Transplantation, Key Laboratory of Combined Multi-Organ Transplantation, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, People’s Republic of China Abstract: Breast cancer (BC) is the most common female malignancy within the spectrum of human cancer. One promising way to reduce the mortality and morbidity of BC is to explore novel diagnostic markers for early diagnosis and prognostication. The neutrophil lymphocyte ratio (NLR) is a good reflection of inflammation, which plays an important role in tumor progression and metastasis. However, the association between NLR and BC prognosis remains unclear. The aim of this meta-analysis is to explore the prognostic value of NLR in BC. Among the screened references in the database, 12 eligible studies were identified in this study. Patients with a higher NLR had a shorter disease-free survival (hazard ratio =1.46, 95% confidence interval: 1.12–1.90, P=0.044) and overall survival (hazard ratio =2.03, 95% confidence interval: 1.41–2.93, P
- Published
- 2016